Literature DB >> 14504193

Androgen receptor gene polymorphism and breast cancer susceptibility in The Philippines.

Alexander Liede1, William Zhang, Maria Lourdes De Leon Matsuda, Alex Tan, Steven A Narod.   

Abstract

Up to one-third of women with breast cancer have a family history of breast cancer, and approximately 5% of cases are attributed to mutations in high-risk breast cancer susceptibility genes, such as BRCA1 and BRCA2. It is believed that genes of lower penetrance, but of greater prevalence, may also modulate a woman's risk of breast cancer. We studied the association of breast cancer and the trinucleotide repeat polymorphism (CAGn) in exon 1 of the androgen receptor gene (AR) in 299 cases of breast cancer and in 229 hospital-based controls from The Philippines. Women for whom the mean length of the CAG repeat allele was < or = 25 units had approximately one-half of the risk of breast cancer compared with women with a mean repeat length of > or = 26 [odds ratio (OR), 0.47; 95% confidence interval (CI), 0.28-0.8). The association with breast cancer risk was particularly strong among older women (> or = 50 years; OR, 0.2; 95% CI, 0.04-0.94). The association was also observed for the longer of the two AR alleles; there was a 5% increase in breast cancer risk for each unit increase in CAG repeat number. These findings support the theory that short trinucleotide repeat genotypes of the AR gene protect against breast cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14504193

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  7 in total

1.  Selected estrogen receptor 1 and androgen receptor gene polymorphisms in relation to risk of breast cancer and fibrocystic breast conditions among Chinese women.

Authors:  Lori C Sakoda; Christie R Blackston; Jennifer A Doherty; Roberta M Ray; Ming Gang Lin; Dao Li Gao; Helge Stalsberg; Ziding Feng; David B Thomas; Chu Chen
Journal:  Cancer Epidemiol       Date:  2010-09-17       Impact factor: 2.984

Review 2.  Trinucleotide repeat expansions in human breast cancer-susceptibility genes: relevant targets for aspirin chemoprevention?

Authors:  M A Altinoz; N E Tunalı
Journal:  Clin Transl Oncol       Date:  2015-07-22       Impact factor: 3.405

3.  Androgen receptor status predicts response to chemotherapy, not risk of breast cancer in Indian women.

Authors:  Pranjal Kulshreshtha; Anurupa Chakraborty; Lc Singh; Ashwani K Mishra; Dinesh Bhatnagar; Sunita Saxena
Journal:  World J Surg Oncol       Date:  2010-08-04       Impact factor: 2.754

4.  Secondary structure at a hot spot for DNA methylation in DNA from human breast cancers.

Authors:  Jarrod Clark; Steven S Smith
Journal:  Cancer Genomics Proteomics       Date:  2008 Sep-Oct       Impact factor: 4.069

Review 5.  CAG repeat polymorphisms in the androgen receptor and breast cancer risk in women: a meta-analysis of 17 studies.

Authors:  Qixing Mao; Mantang Qiu; Gaochao Dong; Wenjie Xia; Shuai Zhang; Youtao Xu; Jie Wang; Yin Rong; Lin Xu; Feng Jiang
Journal:  Onco Targets Ther       Date:  2015-08-13       Impact factor: 4.147

6.  Microsatellites in the estrogen receptor (ESR1, ESR2) and androgen receptor (AR) genes and breast cancer risk in African American and Nigerian women.

Authors:  Yonglan Zheng; Dezheng Huo; Jing Zhang; Toshio F Yoshimatsu; Qun Niu; Olufunmilayo I Olopade
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

7.  Androgen receptor polyglutamine repeat number: models of selection and disease susceptibility.

Authors:  Calen P Ryan; Bernard J Crespi
Journal:  Evol Appl       Date:  2012-06-11       Impact factor: 5.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.